Table 1.

Costs of drugs and hospitalization in the patients with suspected HIT

	Argatroban (n = 11)	Fondaparinux (n = 13)	Rivaroxaban (n = 22)
HIT excluded
Total costs of drugs per patient	1 884* (628; 2 198)	43.2 (9.30; 43.2)	15.4 (6.60; 30.6)
Total costs of hospitalization	92 280 (32 296; 113 844)	65 507 (44 862; 100 652)	59 316 (32 309; 126 008)
Daily costs of hospitalization	4 292 (3 797; 6 325)	3 586 (2 054; 4 874)	3 106 (2 437; 4 624)
HIT confirmed
Total costs of drugs per patient	1 884* (942; 2 198)	43.2 (43.2; 43.4)	24.2 (15.3; 41.8)
Total costs of hospitalization	102 531 (58 331;114 547)	103 994 (44 862;171 506)	111 586 (71 533; 148 504)
Daily costs of hospitalization	4 292 (4 037; 4 564)	3 657 (2 991; 5 039)	3 491 (2 840; 4 624)

Costs are in CHF. We estimated the costs of adverse events using TARMED Tariff.³²

^* Approximates for 1 ampule (250 mg/2.5 mL) of argatroban per day for an 80 kg patient.